Cargando…
Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacy
Precision medicine is starting to incorporate functional assays to evaluate anticancer agents on patient-isolated tissues or cells to select for the most effective. Among these new technologies, dynamic BH3 profiling (DBP) has emerged and extensively been used to predict treatment efficacy in differ...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715649/ https://www.ncbi.nlm.nih.gov/pubmed/36456699 http://dx.doi.org/10.1038/s41698-022-00333-0 |